PowerUp Acquisition (PWUP) Competitors $0.52 +0.10 (+25.07%) As of 07/24/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock PWUP vs. AIMD, CYCN, PHXM, LIXT, ARTL, LSB, IMNN, SNSE, APRE, and CLRBShould you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Ainos (AIMD), Cyclerion Therapeutics (CYCN), PHAXIAM Therapeutics (PHXM), Lixte Biotechnology (LIXT), Artelo Biosciences (ARTL), LakeShore Biopharma (LSB), Imunon (IMNN), Sensei Biotherapeutics (SNSE), Aprea Therapeutics (APRE), and Cellectar Biosciences (CLRB). These companies are all part of the "pharmaceutical products" industry. PowerUp Acquisition vs. Its Competitors Ainos Cyclerion Therapeutics PHAXIAM Therapeutics Lixte Biotechnology Artelo Biosciences LakeShore Biopharma Imunon Sensei Biotherapeutics Aprea Therapeutics Cellectar Biosciences Ainos (NASDAQ:AIMD) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends. Which has more volatility and risk, AIMD or PWUP? Ainos has a beta of 2.13, meaning that its share price is 113% more volatile than the S&P 500. Comparatively, PowerUp Acquisition has a beta of 0.05, meaning that its share price is 95% less volatile than the S&P 500. Do institutionals & insiders hold more shares of AIMD or PWUP? 19.2% of PowerUp Acquisition shares are owned by institutional investors. 10.4% of Ainos shares are owned by company insiders. Comparatively, 48.0% of PowerUp Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is AIMD or PWUP more profitable? PowerUp Acquisition's return on equity of 0.00% beat Ainos' return on equity.Company Net Margins Return on Equity Return on Assets AinosN/A -88.07% -48.60% PowerUp Acquisition N/A N/A N/A Does the media refer more to AIMD or PWUP? In the previous week, Ainos had 1 more articles in the media than PowerUp Acquisition. MarketBeat recorded 1 mentions for Ainos and 0 mentions for PowerUp Acquisition. Ainos' average media sentiment score of 0.63 beat PowerUp Acquisition's score of 0.00 indicating that Ainos is being referred to more favorably in the media. Company Overall Sentiment Ainos Positive PowerUp Acquisition Neutral Which has higher earnings & valuation, AIMD or PWUP? PowerUp Acquisition has lower revenue, but higher earnings than Ainos. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$106.21K101.83-$14.86M-$6.45-0.40PowerUp AcquisitionN/AN/AN/AN/AN/A SummaryAinos and PowerUp Acquisition tied by winning 4 of the 8 factors compared between the two stocks. Get PowerUp Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PWUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PWUP vs. The Competition Export to ExcelMetricPowerUp AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$4.03M$209.81M$2.18B$9.52BDividend YieldN/A3.22%2.57%3.99%P/E RatioN/A1.8822.1420.02Price / SalesN/A585.7591.03104.32Price / CashN/A109.2828.9258.97Price / BookN/A9.3759.775.90Net IncomeN/A-$10.64M-$121.56M$258.50M7 Day Performance45.87%-0.63%0.77%2.12%1 Month Performance90.71%-0.86%2.49%12.62%1 Year Performance-95.38%109.54%25.59%19.25% PowerUp Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PWUPPowerUp AcquisitionN/A$0.52+25.1%N/A-96.3%$4.03MN/A0.00N/AHigh Trading VolumeAIMDAinos1.559 of 5 stars$2.70+2.3%N/A-24.0%$11.07M$20K0.0040CYCNCyclerion Therapeutics2.5328 of 5 stars$3.19-5.3%N/A-8.5%$10.82M$2M-2.7530Positive NewsPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58MN/A0.0049LIXTLixte Biotechnology0.2802 of 5 stars$4.25+8.4%N/A+79.7%$10.52MN/A-2.934ARTLArtelo Biosciences3.0517 of 5 stars$14.17-2.6%$25.00+76.4%+66.2%$10.25MN/A-0.795Gap DownLSBLakeShore Biopharma0.9009 of 5 stars$1.18+9.3%N/A-72.7%$10.05M$80.82M0.00773Positive NewsGap DownIMNNImunon1.9526 of 5 stars$0.62+11.4%$15.50+2,385.6%-58.4%$9.82M$500K0.0030Stock SplitSNSESensei Biotherapeutics4.6504 of 5 stars$7.21-6.5%$90.00+1,148.3%-47.8%$9.72MN/A-0.3140Positive NewsAPREAprea Therapeutics2.9241 of 5 stars$2.08+20.2%$15.50+645.2%-50.1%$9.57M$1.50M-0.887Positive NewsHigh Trading VolumeCLRBCellectar Biosciences2.5399 of 5 stars$5.20-0.6%$375.00+7,111.5%-92.4%$9.47MN/A-0.2410Positive News Related Companies and Tools Related Companies AIMD Competitors CYCN Competitors PHXM Competitors LIXT Competitors ARTL Competitors LSB Competitors IMNN Competitors SNSE Competitors APRE Competitors CLRB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PWUP) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PowerUp Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share PowerUp Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.